Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDH13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANKRD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PMAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS6KC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3HAV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM171 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on